Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Varenicline in the treatment of alcohol use disorders.

Erwin BL, Slaton RM.

Ann Pharmacother. 2014 Nov;48(11):1445-55. doi: 10.1177/1060028014545806. Epub 2014 Aug 5. Review.

PMID:
25095786
2.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
3.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
4.

Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction?

Nocente R, Vitali M, Balducci G, Enea D, Kranzler HR, Ceccanti M.

Am J Addict. 2013 Sep-Oct;22(5):453-9. doi: 10.1111/j.1521-0391.2013.12037.x. Epub 2013 May 15. Review.

PMID:
23952890
5.

Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.

Meszaros ZS, Abdul-Malak Y, Dimmock JA, Wang D, Ajagbe TO, Batki SL.

J Clin Psychopharmacol. 2013 Apr;33(2):243-7. doi: 10.1097/JCP.0b013e3182870551.

PMID:
23422399
6.

Varenicline reduces alcohol self-administration in heavy-drinking smokers.

McKee SA, Harrison EL, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR, Petrakis IL, Estevez N, Balchunas E.

Biol Psychiatry. 2009 Jul 15;66(2):185-90. doi: 10.1016/j.biopsych.2009.01.029. Epub 2009 Feb 27.

7.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
8.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
9.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD006103.

PMID:
17253581
11.

Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.

Hays JT, Croghan IT, Schroeder DR, Ebbert JO, Hurt RD.

J Subst Abuse Treat. 2011 Jan;40(1):102-7. doi: 10.1016/j.jsat.2010.08.009. Epub 2010 Oct 13.

PMID:
20947286
12.

Varenicline decreases alcohol consumption in heavy-drinking smokers.

Mitchell JM, Teague CH, Kayser AS, Bartlett SE, Fields HL.

Psychopharmacology (Berl). 2012 Oct;223(3):299-306. doi: 10.1007/s00213-012-2717-x. Epub 2012 May 1.

13.

[Varenicline, an optional treatment for alcohol dependence syndrome in smokers or non-smokers].

Ebert S, Tetrault JM.

Rev Med Suisse. 2014 Oct 8;10(445):1893. French. No abstract available.

PMID:
25417365
14.

Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.

Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H.

Psychopharmacology (Berl). 2014 Sep;231(18):3799-807. doi: 10.1007/s00213-014-3518-1. Epub 2014 Mar 20.

15.

A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence.

Litten RZ, Ryan ML, Fertig JB, Falk DE, Johnson B, Dunn KE, Green AI, Pettinati HM, Ciraulo DA, Sarid-Segal O, Kampman K, Brunette MF, Strain EC, Tiouririne NA, Ransom J, Scott C, Stout R; NCIG (National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group) Study Group.

J Addict Med. 2013 Jul-Aug;7(4):277-86. doi: 10.1097/ADM.0b013e31829623f4.

16.

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.

West R, Baker CL, Cappelleri JC, Bushmakin AG.

Psychopharmacology (Berl). 2008 Apr;197(3):371-7. Epub 2007 Dec 15.

PMID:
18084743
17.
18.
19.

Varenicline: for smoking cessation.

Rao J, Shankar PK.

Kathmandu Univ Med J (KUMJ). 2009 Apr-Jun;7(26):162-4. Review.

PMID:
20071853
20.

Treatment of nicotine dependence with Chantix (varenicline).

Rankin KV, Jones DL.

Tex Dent J. 2011 May;128(5):457-61.

PMID:
21834368

Supplemental Content

Support Center